A high CD34+ cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors
Yasuhisa Yokoyama, Koichiro Maie, Takahiro Fukuda, Naoyuki Uchida, Junichi Mukae, Masashi Sawa, Kohmei Kubo, Mineo Kurokawa, Hirohisa Nakamae, Tatsuo Ichinohe, Yoshiko Atsuta, Shigeru Chiba
Topics & Concepts
MedicineCD34Hazard ratioTransplantationInternal medicineGastroenterologyHuman leukocyte antigenImmunologyStem cellHematopoietic stem cell transplantationAntigenConfidence intervalGeneticsBiologyHematopoietic Stem Cell TransplantationPlatelet Disorders and TreatmentsRenal Transplantation Outcomes and Treatments